LUPO, Luigi Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 6.593
AS - Asia 2.812
EU - Europa 2.658
SA - Sud America 673
AF - Africa 122
Continente sconosciuto - Info sul continente non disponibili 120
OC - Oceania 7
Totale 12.985
Nazione #
US - Stati Uniti d'America 6.470
SG - Singapore 1.258
IT - Italia 719
CN - Cina 665
BR - Brasile 536
DE - Germania 487
HK - Hong Kong 327
SE - Svezia 315
RU - Federazione Russa 295
UA - Ucraina 194
FI - Finlandia 179
FR - Francia 173
VN - Vietnam 150
GB - Regno Unito 147
IN - India 103
BD - Bangladesh 58
AR - Argentina 56
CA - Canada 52
CI - Costa d'Avorio 50
MX - Messico 39
NL - Olanda 29
IQ - Iraq 28
TR - Turchia 28
BE - Belgio 25
ID - Indonesia 24
ZA - Sudafrica 21
AT - Austria 20
CO - Colombia 20
JP - Giappone 19
EC - Ecuador 17
SA - Arabia Saudita 17
PH - Filippine 16
PL - Polonia 16
IR - Iran 15
CL - Cile 14
IE - Irlanda 14
MY - Malesia 14
ES - Italia 12
PK - Pakistan 12
KE - Kenya 11
UZ - Uzbekistan 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 9
EG - Egitto 9
JO - Giordania 8
PY - Paraguay 8
TT - Trinidad e Tobago 8
MA - Marocco 7
TN - Tunisia 7
CR - Costa Rica 6
OM - Oman 6
AL - Albania 5
AU - Australia 5
AZ - Azerbaigian 5
ET - Etiopia 5
IL - Israele 5
JM - Giamaica 5
KZ - Kazakistan 5
PE - Perù 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
MK - Macedonia 4
NP - Nepal 4
RO - Romania 4
TH - Thailandia 4
BG - Bulgaria 3
BO - Bolivia 3
HN - Honduras 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BY - Bielorussia 2
GE - Georgia 2
GT - Guatemala 2
KI - Kiribati 2
KR - Corea 2
LB - Libano 2
LT - Lituania 2
NI - Nicaragua 2
SN - Senegal 2
TM - Turkmenistan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
CH - Svizzera 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
Totale 12.856
Città #
Singapore 682
Ashburn 628
Fairfield 587
Chandler 505
San Jose 441
Jacksonville 424
Woodbridge 388
Hong Kong 325
Milan 306
Cambridge 261
Nyköping 258
Houston 252
Seattle 232
Wilmington 223
Ann Arbor 221
Beijing 199
Dallas 140
Council Bluffs 129
Munich 127
Lawrence 110
Roxbury 109
Rome 102
Nanjing 98
Lauterbourg 97
Los Angeles 88
New York 86
Des Moines 76
Helsinki 73
Boardman 66
Ho Chi Minh City 59
Abidjan 50
Princeton 48
Santa Clara 45
Shenyang 45
Bari 42
Inglewood 42
Brooklyn 40
São Paulo 38
Columbus 33
Hanoi 32
Jiaxing 32
Buffalo 29
San Diego 29
Figino 28
San Francisco 26
Brussels 24
London 24
Nanchang 24
Chennai 23
Dearborn 23
Eboli 22
Marseille 21
Toronto 21
Chicago 20
Nuremberg 19
Rio de Janeiro 19
Tianjin 19
Tokyo 18
Turin 18
Paris 17
Phoenix 17
Belo Horizonte 16
Montreal 16
Changsha 15
Hebei 15
Atlanta 14
Redwood City 14
Dublin 13
Frankfurt am Main 13
Pune 13
Warsaw 13
Augusta 12
Guangzhou 12
Moscow 12
Orem 12
Amsterdam 11
Ardabil 11
Nairobi 11
Salvador 11
Baghdad 10
Bologna 10
Denver 10
Johannesburg 10
Mexico City 10
Naples 10
Vienna 10
Curitiba 9
Falls Church 9
Kuala Lumpur 9
San Mateo 9
Tashkent 9
Washington 9
Boston 8
Brasília 8
Falkenstein 8
Jakarta 8
Leawood 8
Mumbai 8
The Dalles 8
Zhengzhou 8
Totale 8.602
Nome #
Down-Staging in Liver Transplatation for HCC. Audit of an Experience 230
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 210
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 195
Targeting angiogenesis in biliary tract cancers: An open option 177
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma 173
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 172
Elective versus emergency full thickness rectal prolapse treatment using a perineal approach - a video vignette 164
Protective colostomy closure: the hazards of a "minor" operation 163
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma 163
D-MELD, a strong and accurate tool to guide Donor -2- Recipient Matching 153
A national mandatory-split liver policy: A report from the Italian experience 149
TROMBOPOIETINA E PIASTRINOPENIA NEI PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO (OLT):RISULTATI PRELIMINARI SU 21 PAZIENTI 148
Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection 147
Improved accuracy of computed tomography in local staging of rectal cancer using water enema 145
Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial 143
Reliability of clinical judgement in evaluation of the nutritional status of surgical patients 141
Radiofrequency ablation of HCC on liver cirrhosis. Evaluation of effect by spiral-CT and pathology on native livers of trasplanted patients 140
Accuratezza diagnostica dello staging dell’HCC nei pazienti con cirrosi: la lezione dei trapianti di fegato 140
Is pyloric function preserved in pylorus-preserving pancreaticoduodenectomy? 135
A Bayesan methodology to improve of early graft loss after liver transplantation derived from the Liver Match study 135
Tempo di ischemia fredda e produzione di trombopoietina(TPO) nel trapianto ortotopico di fegato: risultati preliminari su 21 casi 134
Irisin improves the secretory defects of pancreatic islets from type 2 diabetic subjects 131
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. 130
Platelets and hepatocellular cancer: Bridging the bench to the clinics 129
Safe use of Grafts from HBcAb Positive Donors in Liver Transplantation -Analysis of Matching and Outcome 127
Prognostic Value of Neutrophil/Lymphocyte Ratio in Liver Transplantation for HCC 126
Postoperative changes in serum interleukin-2 concentrations 126
Prediction of mortality by logistic regression analysis in patients with postoperative enterocutaneous fistulae. 124
Lipoprotein(a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery 123
Behind D-MELD :the role of primary indication (HCV or HBV) as significant Covariate in the Outcome Prediction after Liver Transplant 123
Laparoscopic management of neuroendocrine tumors: State-of-the-art 122
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 121
MELD predictive value of alterations of brain perfusion during liver transplantation 120
Down-staging in Liver Transplantation for HCC 117
D-MELD, a powerful Instrument to Optimize Donor -2-Recipient Match.Differences betweenUS and Italy 117
Anatomical hepatic resection using radiofrequency thermoablation in the treatment of primary or secondary liver tumors 117
Resection vs radiofrequency ablation for HCC from 3 to 5 cm: A single centre experience on 101 child- pugh class A-B naive patients 116
RUOLO DEL TIPO DI PERFUSIONE NEL PRELIEVO DI FEGATO A SCOPO DI TRAPIANTO 115
RECTAL-CARCINOMA - CT STAGING WITH WATER AS CONTRAST-MEDIUM 115
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial 114
Plasma concentrations but not serum concentrations of brain-derived neurotrophic factor are related to pro-inflammatory cytokines in patients undergoing major abdominal surgery 113
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 113
State of lucid delirium after orthotopic liver transplantation. Clinical case 112
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? 111
Azione della pentossifillina sulla evoluzione in guarigione delle ferite sperimentali nel coniglio 111
Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical out come 110
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 109
Basiliximab vs Steroids in liver transplantation immunosuppression. A prospective randomized clinical trial. 108
[Blood flow assessment with Doppler color ultrasonography in primary and secondary tumors of the liver]. FT Valutazioni flussimetriche con eco color Doppler nei tumori epatici primitivi e secondari. 108
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC 108
ACUTE PANCREATITIS AFTER ORTOTOPIC LIVER TRANSPLANTATION 107
Tempo di ischemia fredda e produzione di trombopoietina(TPO)nel trapianto ortotopico di fegato (OLT): studio preliminare sui primi 9 casi. 107
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 106
TROMBOPOIETINA E PIASTRINOPENIA NEI PZ. SOTTOPOSTI A TRAPIANTO DI FEGATO(OLT): RISULTATI PRELIMINARI SU 21 PZ 104
Increased in vitro and in vivo generation of procoagulant activity (tissue factor) by mononuclear phagocytes after Intralipid infusion in rabbits 104
Evaluation of RFA of HCC in patients underwent LTx: Spiral-CT and Pathology on native livers 104
TROMBOPOIETINA (TPO) E TROMBOCITOPENIA NEI PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO: STUDIO PRELIMINARE SU 9 CASI 103
STATE OF LUCID DELIRIUM AFTER ORTHOTOPIC LIVER TRANSPLANTATION 102
Reliable Steroid-Free Immunosuppression in Liver Transplantation 102
LIVER RELATED EVENTS (LRE) IN PATIENTS WITH ESTABLISHED HCV RECURRENT DISEASE AFTER LIVER TRANSPLANTATION COULD BE PREDICTED BY LIVER STIFFNESS MEASUREMENT (LSM). 101
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosi in 961 patients 100
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 99
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression 99
Liver Match, a prospective observational cohort study on liver transplantation in Italy: Study design and current practice of donor-recipient matching 98
Hepatocellular carcinoma progression is accelerated by cancer associated fibroblasts stimulated by tumor production of lysophosphatidic acid 98
THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS 98
EFFECT OF PERIOPERATIVE WHOLE BLOOD VS LEUCOCYTE-DEPLETED BLOOD TRANSFUSION ON SURVIVAL AFTER CURATIVE SURGERY FOR COLORECTAL 96
Reduction of postoperative immunosuppression with ranitidine in patients with cancer of the stomach or large bowel 95
Radiofrequency ablation of HCC on liver cirrhosis. Evaluation of effect by spiral-CT and pathology on native livers of trasplanted patients 95
Terapia fibrinolitica nel trattamento delle ulcere venose post-flebitiche 93
Solutions for organ perfusion and storage: haemorheologic aspects 93
STUDIO DELL'MCP-1 (MONOCYTE CHEMOATTRACTANT PROTEIN) NEL TRAPIANTO DI FEGATO 92
The tumor microenvironment regulates HCC growth rate 92
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 92
Fattori prognostici nel trattamento sclerosante delle varici esofagee sanguinanti: Studio preliminare 91
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 90
Valutazione prognostica delle fistole enterocutanee post operatorie: confronto fra due sistemi prognostici 90
Manuale di Metodologia della Ricerca ClinicA 89
Reliability and accuracy of the hepatic perfusion index as a diagnostic test for liver metastases. 88
OPTIMIZATION OF DONOR-RECIPIENT MATCH AND IDENTIFICATION OF THE FUTILE MATCH CUTOFF. A NATIONAL ITALIAN STUDY ON LIVER TRANSPLANTATION. 87
Worse Graft Survival in HCV-Infected Transplanted Females Receiving a Male Donor Graft. The Liver Match Study 86
Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage 86
null 86
Limited prognostic value of staging systems for hepatocellular carcinoma on cirrhosis 85
PI3K class 1B controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma 84
Hemorheological and microcirculation in healthy and diseased liver after liver transplantation: a review. 84
Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha 6 beta 4 and alpha 3 beta 1 integrins 82
null 81
[Gene expression of the MAGE-1, -3, and -6 antigens in hepatic carcinoma]. FT Espressione genica degli antigeni MAGE-1, -3, -6 nell'epatocarcinoma. 80
Role of perioperative parenteral nutrition in patients submitted to curative surgery for gastric carcinoma. 80
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma 78
Post-surgical trauma acute inflammation. A molecular analysis 76
null 76
Reliability of clinical judgement in evaluation of the nutritional-status of surgial patients. 75
Liver stiffness measurments is able to predict graft failure in patients with established HCV recurrence after Liver Transplantation 74
Hepatitis B-core antibody positive donors in Liver Trasplantation and their impact on graft survival:Evidence from the Liver Match cohort study 74
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 73
Pushing the limits: Liver Transplantation for HCC beyond the Milan Criteria in the MELD Era (Attraction of forbidden or a rational approach) 73
HSP70 and VEGF blood levels in patients with hepatocellular carcinoma (HCC) 72
Liver transplantation with hepatitis B core antibodypositive graft under hepatitis b Immunoglobulin and lamivudine prophilaxis 72
Totale 11.265
Categoria #
all - tutte 55.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022694 0 0 10 46 21 50 39 49 39 38 138 264
2022/20231.350 182 120 84 118 162 196 18 154 245 7 33 31
2023/2024408 33 81 24 36 38 94 21 23 0 6 11 41
2024/20251.977 22 22 159 44 58 189 189 219 102 85 267 621
2025/20263.996 565 211 287 404 481 206 438 126 332 323 115 508
2026/2027476 123 178 175 0 0 0 0 0 0 0 0 0
Totale 12.985